HPS Pharmacies wish to give notice that all suppliers are currently experiencing an interruption to the supply of norfloxacin tablets as follows:
Norfloxacin Tablets (400mg x 14)
|Brand Name||Brand||ARTG||Expected Return Date|
|GenRX Norfloxacin||GenRx||155546||July 13, 2015|
|Norfloxacin Sandoz||Sandoz||76899||Mid-October 2015|
|Nufloxib||Alphapharm||149416||June 23, 2015|
|Roxin||Aspen||93210||June 25, 2015|
The supply interruption to norfloxacin 400mg tablets is due to unexpected demand resulting from the discontinuation of the Actavis brand, changes at the manufacturing site for the Sandoz brand, and a shortage of the raw ingredient for GenRx. The Alphapharm and Aspen brands are expected to resume full supply next week.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.